The invention discloses a tsRNA-SecTCA-L35 molecule and application of the tsRNA-SecTCA-L35 molecule as a
colorectal cancer diagnosis biomarker and a
colorectal cancer treatment target, and relates to the technical field of biological
medicine. The invention provides application of the tsRNA-SecTCA-L35 molecule as a
colorectal cancer diagnosis biomarker and a treatment target, in the diagnosis level, the molecule as a novel biomarker can be sensitively and specifically detected in samples such as
plasma and tissue through qRT-PCR and other technologies, a brand new tool is provided for early discovery and non-invasive diagnosis of colorectal
cancer, and the application of the tsRNA-SecTCA-L35 molecule as the colorectal
cancer diagnosis biomarker and the treatment target is wide. In the aspect of treatment, by designing an analogue related to the
molecular function and preparing the analogue into a pharmaceutical composition of a carrier such as lipidosome, the expression of the analogue in
tumor cells can be effectively up-regulated, so that the proliferation of
cancer cells is remarkably inhibited
in vivo and
in vitro, the death of the cancer cells is promoted, and the definite anti-tumor activity is shown; the important clinical application value is realized.